División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, Ciudad de México, Mexico.
An Pediatr (Engl Ed). 2022 Aug;97(2):119-128. doi: 10.1016/j.anpede.2022.03.001. Epub 2022 Mar 11.
In the paediatric population, coronavirus disease (COVID-19) is usually asymptomatic or mild, but there are also severe and fatal cases.
We analysed data on COVID-19 cases from the national and state-level databases of the Federal Ministry of Health of Mexico and the Department of Health of Mexico City to determine the clinical characteristics and risk factors for mortality in children. We used Cox proportional hazards regression analysis to calculate the risk of death.
The national and Mexico City databases had recorded a total of 18,465 (2.8%) and 5,733 (4.2%) confirmed cases of COVID-19, respectively, in individuals aged less than 18 years as of September 2020. The median age at diagnosis was 12 years (range: 0-17). The differences between cases in the national vs Mexico City databases were: 12.5% vs 8.2% of patients were hospitalised; 6% vs 3.5% had pneumonia; 2.4% vs 1.9% were admitted to the intensive care unit (ICU), and 1.3% vs 0.7% died. The independent risk factors significantly associated with a higher probability of death were pneumonia, hypertension, obesity, immunosuppression and intubation.
In Mexico, 2.8% of all confirmed cases of COVID-19 occurred in individuals under 18 years, with a median age of 12 years and a mortality of 1.3%. The identified predictors of mortality were pneumonia, admission to the ICU, obesity, hypertension, immunosuppression, diabetes, chronic lung disease and renal disease.
在儿科人群中,冠状病毒病(COVID-19)通常为无症状或轻症,但也有严重和致命病例。
我们分析了墨西哥联邦卫生部和墨西哥城卫生部的国家和州级数据库中关于 COVID-19 病例的数据,以确定儿童中 COVID-19 的临床特征和死亡风险因素。我们使用 Cox 比例风险回归分析计算死亡风险。
截至 2020 年 9 月,国家和墨西哥城数据库分别记录了 18465(2.8%)和 5733(4.2%)例年龄小于 18 岁的确诊 COVID-19 病例。诊断时的中位年龄为 12 岁(范围:0-17)。国家和墨西哥城数据库中的病例之间的差异为:12.5%的患者住院治疗,而 8.2%的患者住院治疗;6%的患者患有肺炎,而 3.5%的患者患有肺炎;2.4%的患者入住重症监护病房(ICU),而 1.9%的患者入住 ICU,而 1.3%的患者死亡,而 0.7%的患者死亡。与死亡概率显著相关的独立危险因素为肺炎、高血压、肥胖、免疫抑制和插管。
在墨西哥,所有 COVID-19 确诊病例中有 2.8%发生在 18 岁以下的人群中,中位年龄为 12 岁,死亡率为 1.3%。确定的死亡预测因素为肺炎、入住 ICU、肥胖、高血压、免疫抑制、糖尿病、慢性肺病和肾脏疾病。